当前位置: 首页 > 期刊 > 《英国医生杂志》 > 2004年第1期 > 正文
编号:11340778
In brief
http://www.100md.com 《英国医生杂志》
     Direct to consumer advertisements to stop: The New Zealand government has decided to overturn the policy allowing direct to consumer advertising of drugs. By March 2004 it plans to have adopted common standards with the Australian government, which bans such advertising but allows disease awareness campaigns.

    Death penalty approved for distribution of fake drugs: India's cabinet has approved the death penalty for those involved in the production and distribution of fake drugs. Amendments to the Drugs and Cosmetics Act, which currently allows imprisonment for several years for such offences, will be moved in the winter session of the Indian parliament.

    MPs to investigate science journals: The House of Commons science and technology committee is to conduct an inquiry into the price and availability of scientific publications. It aims to ensure that researchers can access relevant publications effectively and will also look at the impact of online publishing. (See www.parliament.uk)

    Indian doctor wins damages against the NHS: An employment tribunal has awarded an Indian doctor working in the NHS damages of £635 000 ($1.1m; 903 657) for institutional racism. The award against the Department of Health reflects the fact that Vijay Jadhav was not promoted to a consultant post.

    Chairman of euthanasia society resigns: The UK Voluntary Euthanasia Society has accepted the resignation of its chairman, GP Michael Irwin, who was arrested and later released on bail by police investigating the death of a man who had cancer.

    News extra

    More news stories are available on the BMJ's website

    Related Article

    New Zealand moves to ban direct advertising of drugs

    Bob Burton

    BMJ 2004 328: 68.